Special Situations & Catalysts - Spinoffs, Distress, M&A, and Activism

Special Situations & Catalysts - Event-Driven Value Investing

Standard value investing focuses on company fundamentals-earnings, book value, free cash flow-and assumes markets are reasonably efficient at pricing these over time. Special situations investing focuses on catalyst events-spinoffs, mergers, activism, distress, and other corporate actions-that create time-bound mispricings. When executed correctly, special situations investing can generate 25-50%+ returns in 1-3 years by identifying forced selling, structural value creation, and market inefficiency.

Catalysts Create Time-Bound Value Spinoffs, distressed situations, and activist campaigns have defined timelines and outcomes. A spinoff is completed in X months; a merger closes in Y months; an activist holds a 13% stake and demands change over 18 months. These defined catalysts allow you to construct conviction around specific return scenarios and timelines, unlike traditional investing which requires perpetual assumption about company sustainability.

Spinoffs: Why They Create Value Through Separation and Forced Selling

The Spinoff Value Creation Thesis

A spinoff occurs when a parent company separates one business unit into an independent company. General Electric spun off GE Healthcare (2023). Merck spun off Organon Pharmaceuticals (2021). J&J is splitting into Innovative Medicines ($J), General Consumer Health (renamed Kenvue), and Medtech (renamed Abiomed) (2024-2025). Spinoffs create value through:

1. Strategic Clarity: Parent and spinco now have focused strategies. Investors can value a healthcare company standalone vs. conglomerate discount.

2. Operational Independence: Spinco can make decisions without corporate bureaucracy. It can invest in R&D, M&A, or divestitures without parent approval.

3. Valuation Multiple Expansion: Parent might trade at 10x earnings (conglomerate discount) and spinco at 15x earnings (pure-play premium). Combined, the sum-of-the-parts exceeds parent trading value.

4. Tax Efficiency: Spinoffs can be structured as tax-free reorganizations, avoiding capital gains tax to shareholders.

5. Debt Optimization: Parent might be over-levered (parent with multiple business units managing consolidated debt inefficiently). Spinco can optimize its own leverage.

Forced Selling Dynamics: Institutional index investors (S&P 500 mutual funds) own the parent company because it's S&P 500 eligible. When spinoff is announced, the spinco is initially not S&P eligible. Many institutional investors are forced to sell spinco to maintain index compliance. This forced selling creates a 3-6 month window of undervaluation as institutional holders sell and real value investors accumulate.

Analyzing Spinoffs: Expected Valuation Impact

When a spinoff is announced, estimate sum-of-the-parts value:

1. Parent Standalone Valuation: Remove spinco revenue, EBITDA, capex from parent financials. Value parent business using comparable multiples. JPMorgan Chase analyzing parent (without healthcare) at 15x earnings = $X.

2. Spinco Valuation: Value spinco business using peers in its industry. Healthcare spinco peers trade at 18x earnings → spinco worth $Y.

3. Sum-of-the-Parts: $X + $Y should exceed current parent trading value. If it exceeds by 20%, the spinoff creates $20B in value (if parent is $100B).

Example: J&J's 2024 Separation

J&J (2023): $400B market cap. Investors valued J&J as a diversified healthcare conglomerate at 20x earnings. Post-separation expectations:

• Innovative Medicines (Pure Pharma): 22x earnings, higher growth (comparable to Merck, Eli Lilly)

• General Consumer Health (OTC/Beauty): 16x earnings, lower growth

• Medtech: 20x earnings, steady growth

Sum-of-the-parts valuation: If each receives its peer multiple, combined value might be $430-450B (7-12% value creation). But forced selling might depress spinco multiples 1-2x post-separation, creating temporary 10-15% discount. Entry point: Buy J&J before separation announcement is confirmed (pre-arbitrage), or buy spinco 3 months post-separation when forced selling is complete.

Spinoff Case Studies and Historical Returns

PayPal Spinoff from eBay (2015)

eBay and PayPal were combined despite operating independently. Investors valued conglomerate at 13x earnings. PayPal at peer multiples (30x forward earnings for payment processing) would be worth $45B. eBay at peer multiples (8x earnings for e-commerce) would be worth $60B. Sum-of-the-parts: $105B vs. combined trading at $75B-30% value creation potential.

Post-separation: PayPal traded at $35-45 post-spin for 18 months, then rose to $70+ as growth became evident and forced selling abated. eBay slowly recovered as management improved execution. Holders of eBay who bought 6 months post-separation saw 35% returns over 3 years. The opportunity window: 6-18 months post-separation is when both spinco and parent are stabilizing operationally while valuations are still depressed.

Organon Spinoff from Merck (2021)

Merck spun off Organon (women's health, biosimilars) into standalone company trading at $25-35 initially. By 2024, Organon was $17 (value trap). The lesson: Not all spinoffs create value. Organon was slow-growth, high-debt business. While sum-of-the-parts math suggested value creation, the business couldn't sustain dividend and debt levels post-separation. Entry point: Know the spinco's business quality and capital structure before buying.

Healthcare Spinoffs from Conglomerates (ITT Exelis, Dupont Spun Dowdupont)

ITT Corporation spinoff of Exelis (2011): ITT spun off aerospace/defense business (Exelis) in 2011 at $27/share. By 2014, Harris Corp (competitor) acquired Exelis at $35/share (30% return). The lesson: Sometimes spincos are acquisition targets within 3 years. Monitor activist investors, industry consolidation, and potential acquirers post-separation.

Spinoff Thesis = Forced Selling + Multiple Expansion + Operational Improvement Don't just buy a spinco because sum-of-the-parts math suggests value creation. Analyze the quality of the spinco's business (growth, margins, ROIC), assess forced selling impact (what % of shares held by indexers will need to sell?), and identify operational improvements (cost reduction, investment rate changes) that could drive multiples and earnings. All three together = exceptional returns.

Distressed & Turnarounds: When to Buy Into Bankruptcy

Distressed Investing Fundamentals

A company in financial distress (high leverage, declining cash flow, missed debt covenants) faces bankruptcy risk. Distressed investing involves buying equity or debt of companies facing restructuring, with the thesis that: (a) the company will emerge as going concern, or (b) equity holders will recover some value in reorganization. Distressed debt trades at 30-60 cents on dollar. Distressed equity trades at 70-90% discount to historical or book value.

The opportunity: Most institutional investors are forced to sell distressed securities (risk limits, covenant violations trigger automatic selling). This selling depresses prices below intrinsic reorganization value. Value investors with conviction and ability to hold through bankruptcy can earn 50-200%+ returns if company emerges.

Bankruptcy Reorganization Process (US, Chapter 11):

1. Filing: Company files Chapter 11, gets automatic stay (creditors can't pursue claims). Management continues operations under bankruptcy court supervision.

2. Prepackaged vs. Unprepackaged: Prepackaged bankruptcies (company plans restructuring pre-filing) move faster. Unprepackaged bankruptcies (management figures out plan post-filing) take 1-3 years.

3. Secured vs. Unsecured Creditors: Secured creditors (have collateral) get paid first. Unsecured creditors (no collateral) get paid second. Equity (residual claim) gets paid last.

4. New Equity Issuance: In reorganization, existing equity is often wiped out. New equity is issued to debt holders who accept restructuring plan. Equity holders suffer ~100% loss.

5. Emergence: Company emerges with lower debt, new management, and fresh equity structure. New equity holders (previous debt holders) own going concern.

When to Invest in Distressed Companies

Thesis 1: Balance Sheet Restructuring Without Operational Failure

Company has strong operations (cash flow positive, competitive position intact) but overleveraged balance sheet. Example: Neiman Marcus, a luxury retailer, filed bankruptcy in 2020 (COVID closure forced store shutdowns and debt covenant violation). Operationally, Neiman Marcus was a healthy business-luxury customers continued spending, demand post-reopening was strong. Equity purchased at $0.01/share by activist investor Ares (restructuring expert) emerged from bankruptcy at $2-5/share (200-500x return). The thesis: Balance sheet restructuring, not operational turnaround, drives value.

Analysis framework:

1. Calculate operational cash flow (excluding financing and investing activities) for last 3 years. Is OCF positive and stable?

2. Identify debt maturity schedule. When is near-term refinancing needed? Is it feasible?

3. Model restructuring scenarios: if debt is reduced 30%, would company be healthy? 50%?

4. Assess competitive position: are competitors gaining market share, or are margins stable?

Thesis 2: Cyclical Bottom + Financial Distress = Exceptional Opportunity

Company is cyclical (auto suppliers, mining, industrials) and faced cyclical downturn while also highly leveraged. Distress is temporary. Example: Ford (2008): Filed for credit line, not bankruptcy, but was borderline. Auto cycle was severely depressed. Investors buying Ford at $1-2/share in 2009 (equity was down 90%+) benefited from: (a) auto cycle recovery (2010-2015), and (b) balance sheet repair. Stock recovered to $15+ (600%+ return).

Analysis framework:

1. Is the company's industry cyclical? If so, where in the cycle are we (trough, recovery, expansion, peak)?

2. Has the company ever cycled through recovery before? What was cash flow generation and deleveraging pace?

3. What's the worst-case scenario (company can't achieve recovery)? What's upside if cycle recovers?

Thesis 3: Activist Turnaround: New Management, New Strategy

Company has solid assets but mismanagement. Activist investor acquires stakes, installs new management, and executes operational turnaround. Example: Apple under Steve Jobs (1997-2011): Investors thought Apple was dead. Jobs returned, cut costs, and launched iPhone. Stock recovered from $16 to $300+ (18x return). Activist Catalyst: Jobs' appointment created existential change in strategy.

Analysis framework:

1. What's currently wrong with the company? Cost structure, product strategy, market position?

2. Is there a credible turnaround plan? How long would it take?

3. Has the activist investor succeeded before? Track record matters.

4. What's probability activist succeeds? Rate 20%, 50%, 80%? Model downside if it fails.

The Distressed Debt vs. Equity Decision

When a company is distressed, you can own debt or equity. Distressed debt is safer (gets paid first in bankruptcy) but offers lower upside (capped at coupon + par). Distressed equity is riskier (gets wiped out in bankruptcy) but offers unlimited upside (if company recovers, equity recovers 200-1000x).

Portfolio construction: Professional distressed investors typically own a portfolio of distressed situations-50% in higher-probability plays (50% recovery), 30% in medium-probability (100-200% return), 20% in long-shot equity (1000%+ return but 30% probability). Diversification is critical because bankruptcy outcomes are binary (recovery or loss).

Distressed Investing = Event-Driven + Fundamental Analysis + Probability Assessment Don't buy distressed securities because they're cheap. Buy them because you understand the turnaround plan, assess probability of recovery at >50%, and have conviction the recovery value exceeds current trading price. Most distressed securities fail-only invest if you've done deep operational and financial analysis.

Merger Arbitrage: Deal Spread Calculation and Risk Assessment

Merger Arbitrage Mechanics

Merger arbitrage (M&A arbitrage) is buying a company being acquired and selling the acquirer (if stock deal) or holding cash risk (if cash deal). The strategy profits from the deal spread-the difference between announcement price and current market price.

Example: Stock Deal

Company A announces it will acquire Company B for $50/share in 1 million A shares + $500M cash (total $1.5B deal). B is currently trading at $45/share. The deal spread is $5 ($50 - $45 = 11% upside). Expected timeline: 9 months to close (regulatory approval, shareholder votes).

M&A arbitrageur buys B at $45, shorting A (because A is issuing stock to fund deal). The profit is captured if:

1. Deal closes at announced price: Arbitrageur made $5/share on B long ($45 → $50), hedged against A's issuance dilution by shorting A (profit on short offsets dilution loss).

2. Deal spread compressed: If market thinks deal is more likely to close, B rises to $48, shorting A likely rises too (offsetting gains), but arbitrageur benefits from reduced deal risk.

Example: Cash Deal

Company A announces it will acquire Company B for $50/share in cash (total $1.5B deal). B trades at $45/share. Deal spread is $5/share. Timeline: 12 months.

M&A arbitrageur buys B at $45, earns $5/share when deal closes. No short-sale hedge needed because deal is all-cash (no dilution risk to A). Profit is purely the deal spread, adjusted for time (9% return, annualized is 12% over 9 months).

Deal Spread Components

Deal spread compensates for three risks:

1. Regulatory Risk: Government might block acquisition on antitrust grounds. More significant for large deals in concentrated industries. Estimate probability: 90% (low risk) → spread is 2-3%. 50% (high risk) → spread is 8-15%. Track FTC/DOJ antitrust enforcement patterns to estimate risk.

2. Financing Risk: Acquirer might lack financing (especially relevant for all-stock deals where stock prices depend on announcement). If acquirer stock falls post-announcement, equity investors might vote against deal. Estimate probability: 90% financing closes → spread 2-4%. 70% financing closes → spread 6-12%.

3. Timing Risk: Time value of money. A 5% return over 12 months = 5% return. A 5% return over 6 months = 10% annualized. Longer timelines compress deal spreads (extend closing, reduce annualized return).

Analyzing Deal Risk

Monitor deal closing factors:

1. Antitrust Filing Progress: When deal is announced, look for Hart-Scott-Rodino (HSR) filing (US) or equivalent. Once HSR is filed, there's 30-day waiting period. If FTC/DOJ doesn't challenge, deal is likely to proceed. Second Request delays typically indicate regulatory risk.

2. Shareholder Votes: Acquisition requires both companies' shareholders to approve. If shareholder base is activist-heavy or institutional, voting can be uncertain. Monitor institutional investor statements in proxy filings.

3. Financing Commitment: In cash deals, look for committed financing letter. If financing is not committed, deal risk is elevated. In stock deals, acquirer stock price is critical-if stock falls >15% post-announcement, deal could be renegotiated.

4. Competing Bids: If target receives competing bids, deal spread can expand (option value on eventual buyer identity). Monitor for competing bidders.

M&A Arbitrage Case Studies

Elon Musk's Twitter Acquisition (April 2022)

Musk announced $54.20/share all-cash acquisition of Twitter ($44B deal). Twitter stock was trading at $45 pre-announcement. Deal spread: $9.20 ($54.20 - $45 = 20% return). Timeline: Estimated 6 months. Expected return: 20% over 6 months = 40% annualized (exceptional).

Risk assessment: Financing was a concern (Musk's financing was contingent on debt markets staying open, and debt financing terms deteriorated post-announcement). By June 2022, Musk walked away from deal, and Twitter fell back to $33. M&A arbitrageurs who bought at $45 lost 26% when deal fell through. The lesson: Financing risk in stock/contingent deals is real. Elon's leverage and margin calls on Tesla stock if stock fell made deal completion uncertain.

Outcome: Deal eventually closed at $54.20 after Elon was forced into court settlement. Late arbitrageurs made 20% returns. Early arbitrageurs made less (deal took 7+ months, not 6 months estimated).

Microsoft-Activision Blizzard ($ATVI, Jan 2022)

Microsoft announced $68.70/share acquisition of Activision ($75B deal). Stock trades at $65. Deal spread: $3.70 (5.7% return). Timeline: 18+ months (major regulatory scrutiny expected-gaming consolidation in crosshairs). Expected return: 5.7% over 18 months = 3.8% annualized (low).

Risk assessment: Antitrust risk was substantial. Both FTC (US), UK CMA, and EU regulators were scrutinizing. Spread of only 5.7% reflected perceived deal risk. In December 2022, UK CMA blocked deal initially (causing stock to fall to $60, deal spread compressed to $8.70, or 14.5% return expectation on remaining timeline of 2 months). In October 2023, CMA eventually approved deal, and it closed. Those who arbitraged from deal announcement to close made 5.7% over 21 months (3.2% annualized)-low return for risk taken.

Arbitrage Thesis = Deal Spread / Time - Risk Discount Calculate annualized return: (Deal Spread / Current Price) / (Months to Close / 12). Compare to risk-free rate + risk premium. If annualized return is 6% for a 10% risk event, expected value is 6% × 90% - 30% × 10% = 5.4% - 3% = 2.4%. If risk-free rate is 4%, the M&A arbitrage is not attractive. Conduct full expected value analysis before committing capital.

Activist Investing: 13D Filings and Riding Alongside Activists

Understanding 13D Filings

A 13D is a filing with the SEC when someone acquires >5% of a company's outstanding shares with intent to influence corporate policy. The 13D must disclose: investor identity, stake size, funding source, and intended action (activist agenda). 13D filings are goldmines for understanding activist playbooks.

Example: Starboard Value's Vista Equity Investment (2023)

Starboard Value (activist hedge fund) acquired 5.2% stake in Vista Equity Partners (private equity firm recently listed on NASDAQ). The 13D outlined Starboard's thesis: Vista should increase dividend, accelerate software-only focus (exit hardware), cut costs. Vista stock was trading at $45 post-IPO weakness. Starboard's push for dividends and strategic clarity drove stock to $60+ over 12 months.

Activist Playbook Patterns

Most activists follow similar playbooks:

1. Dividend & Shareholder Returns: "Company is generating excess cash but not returning it to shareholders. Activist demands dividend increase, buybacks, or special dividends."

2. Cost Reduction & Margin Expansion: "Company is bloated with legacy costs. Activist demands headcount reduction, outsourcing, scale consolidation."

3. Strategic Refocus: "Company operates in unrelated businesses (conglomerate discount). Activist demands spinoff or divestiture of non-core."

4. Board Representation: "Board is captured, not independent. Activist demands director appointments, removal of bad directors."

5. Asset Sales & Capital Deployment: "Company is sitting on excess assets (real estate, intellectual property). Activist demands monetization and redeployment."

6. Management Change: "CEO is not aligned with shareholder interest. Activist demands management replacement."

Identifying Activist-Prone Companies

Companies most vulnerable to activism:

1. Conglomerate Discount: Company worth 20% less if broken up (sum-of-the-parts > trading value). Examples: Berkshire Hathaway (never activist target-Buffett is genius), Danaher (periodic activist attention).

2. Cost Structure Misalignment: Company has 25% operating margins while peers have 35%. Cost reduction opportunity is 1000+ bps. Example: IBM (high-cost infrastructure, activism pressure in 2010s).

3. Excess Cash / Low Dividend: Company has $5B cash on balance sheet, zero dividend. Activist demands "return capital to shareholders." Example: Apple (pre-2012; Tim Cook implemented massive buyback program).

4. Strategic Misalignment: Company operates in mature, low-growth markets but competes against businesses in high-growth TAMs. Activist demands M&A, acquisitions in growth markets. Example: Kraft Heinz (faced activist pressure to enter faster-growing snacking).

5. Management Overpayment: CEO compensation is 200x median employee salary (rare in US, common in emerging markets). Governance activists demand compensation alignment.

Riding Alongside Activists

When an activist acquires a 5%+ stake and files 13D, public investors can "ride alongside" by:

1. Buying the target stock once activist thesis is clear, betting that activism will drive the stock up 20-50%.

2. Timing entry: Buy AFTER the 13D filing (price spike from activist disclosure), but BEFORE the activist wins (price rises more). The best returns come for investors who discover the activist thesis 3-6 months after filing, when the market hasn't yet priced in the outcome.

Riding Alongside Case Study: Spartan Energy (SPXT, 2020s)

Spartan Energy was a midstream energy company trading at depressed valuations (3x EBITDA, dividend yield 10%+). Activist investor Brookfield Infrastructure bought stake and proposed restructuring (simplify to focus on core midstream, divest commodities trading, increase dividend). The activist thesis was: Company is worth 6x+ EBITDA if refocused, and dividend can double with cost cuts.

Ride-alongside investors who bought SPXT after Brookfield 13D filing saw 40%+ returns over 2 years as Brookfield's thesis played out (restructuring completed, dividend increased, valuation multiple expanded). Entry was $25/share, exit $35/share.

The key: Don't buy on activist announcement day (market has already priced in initial pop). Wait 3-6 months, reassess activist progress, and buy if you think activist will succeed but market hasn't yet fully priced it in.

Sum-of-the-Parts Arbitrage: Conglomerate Discount Opportunities

Calculating Sum-of-the-Parts Value

Sum-of-the-parts (SOTP) valuation breaks a conglomerate into business units and values each independently using peers' multiples. If SOTP > trading value, the conglomerate trades at discount. If discount is >30%, the company is a restructuring candidate (breakup, spinoff, activist target).

Example: Honeywell International ($HON, 2024)

Honeywell operates four segments: Aerospace Systems, Automation and Control, Performance Materials, and Advanced Materials. Each segment has different growth, margins, and multiples:

• Aerospace Systems: $15B revenue, 20% EBITDA margin, 12x EBITDA multiple (peer) = $3.6B value

• Automation and Control: $12B revenue, 22% EBITDA margin, 14x EBITDA multiple = $3.7B value

• Performance Materials: $10B revenue, 18% EBITDA margin, 11x EBITDA multiple = $2.0B value

• Advanced Materials: $8B revenue, 16% EBITDA margin, 10x EBITDA multiple = $1.3B value

Sum-of-the-parts: $10.6B (enterprise value)

Add: Cash $3B, Subtract: Debt $6B = Equity Value $7.6B / 750M shares = $10.13/share implied.

If Honeywell trades at $200/share, the conglomerate is NOT trading at discount (it's premium). This means market values the conglomerate more than sum-of-parts, attributing value to integrated operations, scale, cross-selling. This is the opposite of conglomerate discount-it's conglomerate premium (management is efficient and creates synergies).

Conglomerate Discount Opportunity: Berkshire Hathaway ($BRK)

Berkshire Hathaway operates Insurance (GEICO, Berkshire Reinsurance), Banking (BofI stake), Railways (BNSF), Utilities (Berkshire Hathaway Energy), Industrials (Precision Castparts, Marmon), and increasingly cash. Market values Berkshire at ~$1.7T market cap. Sum-of-the-parts estimate:

• Insurance: $200B value (20% of Berkshire market cap, reasonable for insurance float + earnings)

• Banking/Investments: $600B (stocks, bonds, cash generating returns)

• BNSF Railway: $100B

• BHE Utilities: $200B

• Industrials and Manufacturing: $250B

• Other/Cash: $350B

Sum-of-the-parts: ~$1.7T. Berkshire trades roughly at SOTP value, not at conglomerate discount. Why? Because Buffett's reputation and capital allocation track record are so strong that investors value the holding company's optionality and patient capital deployment at fair value.

Timing SOTP Opportunities

Conglomerate discount is widest when:

1. Weak Macro: Recession, rising rates, market downturn. Investors are forced to sell all holdings (including unloved conglomerate stocks). Selling pressure pushes discount to extremes.

2. Weak Sentiment: Conglomerate model is out of favor (2015-2020, activism was highlighting synergy destruction in some conglomerates). Investors prefer "pure plays."

3. Management Change: New CEO might have different strategy (spin businesses, focus, etc.). Market uncertainty widens discount.

Entry point: Buy conglomerates trading at 25-40% discount to SOTP during weak macro/sentiment. Exit: Sell when discount compresses to 10-15% or when catalyst (spinoff, breakup, activist win) is realized.

SOTP = Catalyst Play Don't buy a conglomerate at SOTP discount on the thesis that "the market will eventually figure it out" (passive approach). Buy because: (1) management has signaled breakup plan (active catalyst), (2) activist has filed 13D (forced catalyst), or (3) macro/sentiment is so weak that discount to SOTP is temporary. Without catalyst, discount can persist indefinitely.

Special Situations Summary and Portfolio Construction

Special situations investing requires:

1. Catalyst Timeline: Define when catalyst will occur (spinoff in Q2 2025, activist 18-month plan, deal closes Q1 2026). Build position with catalyst timeline in mind.

2. Probability Assessment: Estimate success probability for each scenario (spinoff goes through: 85%, offer gets renegotiated downward: 15%). Model expected value.

3. Position Sizing: Size position based on conviction and risk. 5-10% position for high-conviction (70%+ success probability). 1-3% for medium conviction. Don't oversize-binary outcomes require diversification.

4. Catalyst Monitoring: Track developments quarterly. Has timeline slipped? Is management signaling deal renegotiation? Update conviction and position accordingly.

5. Exit Discipline: Set exit criteria. If catalyst fails, exit immediately (don't hope). If catalyst succeeds and returns are realized, exit (don't get greedy holding post-catalyst).

Self-Practice Prompts

Spinoff Analysis: Find an announced spinoff (e.g., Mondelez splitting out coffee business, or future separations announced). Calculate sum-of-the-parts pre-separation. Model forced selling impact (what % of current shareholders are index funds forced to sell spinco?). Estimate undervaluation window and return opportunity.

Distressed Situation: Find a distressed company (CCC credit rating, high leverage, declining cash flow). Calculate pro-forma debt/EBITDA if company is restructured. Estimate equity recovery value in bankruptcy. What's the probability company emerges successfully? What's equity recovery value if it does?

Merger Arbitrage: Find an announced M&A deal. Calculate deal spread and annualized return. Assess regulatory risk (consult FTC/CMA/EU enforcement history). Model deal success probability. Calculate expected value of arbitrage position. Is expected return > risk-free rate + appropriate risk premium?

Activist Thesis: Find a company with 5%+ activist stake (disclosed in 13D). Research activist's track record. Does their thesis make sense to you? Do you think they'll win? Would you ride alongside or avoid? What's your conviction probability?

SOTP Breakdown: Find a conglomerate (e.g., 3M, Danaher, ITT Holdings). Break down into business units. Value each segment using peer multiples. Calculate SOTP value. Compare to current trading valuation. Is SOTP discount >25%? What would it take to close the gap (spinoff, activist, management change)?